These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 15233578)

  • 41. [Therapeutic trial in a family with late cerebellar atrophy].
    Gracia Naya M; Pina Latorre MA
    Neurologia; 1991 May; 6(5):188-9. PubMed ID: 1908256
    [No Abstract]   [Full Text] [Related]  

  • 42. Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia.
    Goff DC; Tsai G; Manoach DS; Coyle JT
    Am J Psychiatry; 1995 Aug; 152(8):1213-5. PubMed ID: 7625475
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The treatment of spinocerebellar ataxias: facts and hypotheses.
    Botez MI; Botez-Marquard T; Mayer P; Marchand L; Lalonde R; Reader TA
    Med Hypotheses; 1998 Nov; 51(5):381-4. PubMed ID: 9848465
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The cerebellar serotoninergic system and its possible involvement in cerebellar ataxia.
    Trouillas P
    Can J Neurol Sci; 1993 May; 20 Suppl 3():S78-82. PubMed ID: 8334597
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Ataxia in rolling mouse Nagoya and the norepinephrine system--a psychopharmacological study].
    Matsui K; Toyoshima E; Mano U; Ando K
    Yakubutsu Seishin Kodo; 1982 Dec; 2(2):77-80. PubMed ID: 6821292
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [A case of Cockayne syndrome with cerebellar ataxia improved after TRH therapy (author's transl)].
    Naito H
    Horumon To Rinsho; 1982 Mar; 30(3):261-6. PubMed ID: 6807582
    [No Abstract]   [Full Text] [Related]  

  • 47. Selective increase in the extracellular D-serine contents by D-cycloserine in the rat medial frontal cortex.
    Fujihira T; Kanematsu S; Umino A; Yamamoto N; Nishikawa T
    Neurochem Int; 2007; 51(2-4):233-6. PubMed ID: 17662507
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder.
    de Kleine RA; Hendriks GJ; Kusters WJ; Broekman TG; van Minnen A
    Biol Psychiatry; 2012 Jun; 71(11):962-8. PubMed ID: 22480663
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of cerebellar ataxia with buspirone: a double-blind study.
    Trouillas P; Xie J; Adeleine P
    Lancet; 1996 Sep; 348(9029):759. PubMed ID: 8806320
    [No Abstract]   [Full Text] [Related]  

  • 50. Absence of significant interactive effects of high-dose D-cycloserine and ethanol in healthy human subjects: preliminary insights into ethanol actions at the glycine B site of NMDA glutamate receptors.
    Trevisan L; Petrakis IL; Pittman B; Gueorguieva R; D'Souza DC; Perry E; Limoncelli D; Krystal JH
    Alcohol Clin Exp Res; 2008 Jan; 32(1):36-42. PubMed ID: 18028532
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regression of cerebellar syndrome with long-term administration of 5-HTP or the combination 5-HTP-benserazide.
    Trouillas P
    Ital J Neurol Sci; 1984 Sep; 5(3):253-66. PubMed ID: 6334064
    [TBL] [Abstract][Full Text] [Related]  

  • 52. D-cycloserine augmented exposure therapy for obsessive-compulsive disorder.
    Kushner MG; Kim SW; Donahue C; Thuras P; Adson D; Kotlyar M; McCabe J; Peterson J; Foa EB
    Biol Psychiatry; 2007 Oct; 62(8):835-8. PubMed ID: 17588545
    [TBL] [Abstract][Full Text] [Related]  

  • 53. TRH treatment in cerebellar ataxia following a lightning stroke.
    Morocutti C; Spadaro M; Amabile G
    Ital J Neurol Sci; 1989 Oct; 10(5):531. PubMed ID: 2509400
    [No Abstract]   [Full Text] [Related]  

  • 54. Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear.
    Ressler KJ; Rothbaum BO; Tannenbaum L; Anderson P; Graap K; Zimand E; Hodges L; Davis M
    Arch Gen Psychiatry; 2004 Nov; 61(11):1136-44. PubMed ID: 15520361
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Buspirone in the treatment of cerebellar ataxia].
    Svetel M; Vojvodić N; Filipović SR; Dragasević N; Sternić N; Kostić VS
    Srp Arh Celok Lek; 1999; 127(9-10):312-5. PubMed ID: 10649900
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Delay aversion: effects of 7-OH-DPAT, 5-HT1A/1B-receptor stimulation and D-cycloserine.
    van den Bergh FS; Bloemarts E; Groenink L; Olivier B; Oosting RS
    Pharmacol Biochem Behav; 2006 Dec; 85(4):736-43. PubMed ID: 17208285
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A preliminary study of the efficacy of ondansetron in the treatment of ataxia, poor balance and incoordination from brain injury.
    Mandelcorn J; Cullen NK; Bayley MT
    Brain Inj; 2004 Oct; 18(10):1025-39. PubMed ID: 15370901
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Action of physostigmine on inherited ataxias.
    Rodriguez-Budelli MM; Kark RA; Blass JP; Spence MA
    Adv Neurol; 1978; 21():195-202. PubMed ID: 735925
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of D-cycloserine on extinction: translation from preclinical to clinical work.
    Davis M; Ressler K; Rothbaum BO; Richardson R
    Biol Psychiatry; 2006 Aug; 60(4):369-75. PubMed ID: 16919524
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacological investigations of the cholinergic imbalance hypotheses of movement disorders and psychosis.
    Davis KL; Berger PA
    Biol Psychiatry; 1978 Feb; 13(1):23-49. PubMed ID: 146524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.